The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Open accessAbstract
Nonalcoholic steatohepatitis (NASH) is a manifestation of systemic metabolic disease related to obesity, and causes liver disease and cancer 1,2. The accumulation of metabolites leads to cell stress and inflammation in the liver 3, but mechanistic understandings of liver damage in NASH are incomplete. Here, using a preclinical mouse model that displays key features of human NASH (hereafter, NASH mice), we found an indispensable role for T cells in liver immunopathology. We detected the hepatic accumulation of CD8 T cells with phenotypes that combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics. Liver CXCR6+ CD8 T cells were characterized by low activity of the FOXO1 transcription factor, and were abundant in NASH mice and in patients with NASH. Mechanistically, IL-15 induced FOXO1 downregulation and CXCR6 upregulation, which together rendered liver-resident CXCR6+ CD8 T cells susceptible to metabolic stimuli (including acetate and extracellular ATP) and collectively triggered auto-aggression. CXCR6+ CD8 T cells from the livers of NASH mice or of patients with NASH had similar transcriptional signatures, and showed auto-aggressive killing of cells in an MHC-class-I-independent fashion after signalling through P2X7 purinergic receptors. This killing by auto-aggressive CD8 T cells fundamentally differed from that by antigen-specific cells, which mechanistically distinguishes auto-aggressive and protective T cell immunity.
Overview
CoChat Summary
## TL;DR
This paper argues that liver-resident CXCR6+ CD8 T cells are a key driver of liver immunopathology in NASH. In a mouse NASH model and in patients with NASH, these cells showed a CXCR6/granzyme/PD1 phenotype, low FOXO1 activity, and auto-aggressive killing linked to IL-15, metabolic stimuli, and P2X7 signaling.
## Key findings
- Using a preclinical mouse model that displayed key features of human NASH, the authors found an “indispensable role” for T cells in liver immunopathology.
- They detected hepatic CD8 T cells combining tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics.
- CXCR6+ CD8 T cells had low FOXO1 activity and were abundant both in NASH mice and in patients with NASH.
- Mechanistically, IL-15 induced FOXO1 downregulation and CXCR6 upregulation; together with metabolic stimuli such as acetate and extracellular ATP, this triggered auto-aggression and MHC-class-I-independent killing through P2X7 purinergic receptors.
## Methods
- Preclinical mouse model of NASH with “key features of human NASH”; the paper also compared findings with patients with NASH.
- The analysis focused on hepatic CD8 T cells, assessing phenotype, FOXO1 activity, transcriptional signatures, and killing behavior.
- Main mechanistic tests examined the effects of IL-15 and metabolic stimuli (including acetate and extracellular ATP), and implicated P2X7 signaling in auto-aggressive killing.
## Limitations
- The paper states that mechanistic understandings of liver damage in NASH are incomplete; this is the knowledge gap motivating the study.
- The text provided does not state specific numerical sample sizes, effect sizes, or cohort characteristics for the mouse model or patient analyses.
- Evident from the text: the core mechanistic claims are based on a preclinical mouse model plus observations in patients with NASH, so the extent of causal inference in humans is not fully established in the provided text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 0 Not checked · 12 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We detected the hepatic accumulation of CD8 T cells with phenotypes that combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here, using a preclinical mouse model that displays key features of human NASH (hereafter, NASH mice), we found an indispensable role for T cells in liver immunopathology.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“CXCR6 + CD8 T cells from the livers of NASH mice or of patients with NASH had similar transcriptional signatures, and showed auto-aggressive killing of cells in an MHC-class-I-independent fashion after signalling through P2X7 purinergic receptors.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Liver CXCR6 + CD8 T cells were characterized by low activity of the FOXO1 transcription factor, and were abundant in NASH mice and in patients with NASH.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“CXCR6 + CD8 T cells from the livers of NASH mice or of patients with NASH had similar transcriptional signatures, and showed auto-aggressive killing of cells in an MHC-class-I-independent fashion after signalling through P2X7 purinergic receptors.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
3 more claims
Create a free account to see all 12 claims and every source verdict.
- It may state two separate claims as one. 3
- Probably not a substantial claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We delineated a fibrosis-related enrichment of CD8+ TEM cells harboring a previously reported exhausted signature31,34,35 in the liver, whereas the frequency of CD8+ TEMRA cells increased in the peripheral blood with liver steatosis as assessed by CAP”
From Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preclinical evidence has shown impaired immune surveillance and ICI-induced auto-aggressive T cells in pure MASH-HCC.”
From Etiology-Based Treatment for Unresectable/Advanced Hepatocellular Carcinoma: Focus on Viral Hepatitis and Metabolic Dysfunction-Associated Steatohepatitis (2025) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, educated CD8+ T cells, such as CXCR6+PD-1+CD8+ T cells, are able to elicit auto-aggressive killing of liver cells, accelerating the MASH-to-HCC transition [16].”
From Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC (2025) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In studies on murine models of metabolic dysfunction-associated steatotic liver disease (MASLD), associated with hepatocellular carcinoma (HCC)(133, 134), it was noticed that there was an accumulation of activated hepatic CD8+ T cells with markers indicating tissue residency.”
From The liver as a central "hub" of the immune system: pathophysiological implications (2025) · cites this paper as [133]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This accumulation was linked to immune mediated liver damage and the progression of HCC.”
From The liver as a central "hub" of the immune system: pathophysiological implications (2025) · cites this paper as [133]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
Self-citation
Cited by
Immunotherapies for hepatocellular carcinoma
Llovet, J. M., Castet, F., Heikenwalder, M., Maini, M. K., Mazzaferro, V., Pinato, D. J., Pikarsky, E., Zhu, A. X., & Finn, R. S. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00573-2 · Cited by 1,843
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294
Self-citationMASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Targher, G., Byrne, C. D., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330595 · Cited by 897
Self-citationHepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
Self-citationThe liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Donne, R., & Lujambio, A. (2023) · Hepatology · doi:10.1002/hep.32740 · Cited by 631
“showed an increase of unconventional resident activated and exhausted hepatic CXCR6+ PD‐ 1+CD8+ T cells in the choline‐deficient high‐fat diet mouse model and human NASH tissue: these cells participate in tissue autoaggression and may favor HCC development by reinforcing CLD.[198,199] The majority of HCCs are not enri…”
Background
Metadata
- Authors
- Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., Inverso, D., Wigger, J., Sebode, M., Öllinger, R., Rad, R., Hegenbarth, S., Anton, M., Guillot, A., Bowman, A., Heide, D., Müller, F., Ramadori, P., Leone, V., Garcia-Caceres, C., Gruber, T., Seifert, G., Kabat, A. M., Mallm, J.-P., Reider, S., Effenberger, M., Roth, S., Billeter, A. T., Müller-Stich, B., Pearce, E. J., Koch-Nolte, F., Käser, R., Tilg, H., Thimme, R., Boettler, T., Tacke, F., Dufour, J.-F., Haller, D., Murray, P. J., Heeren, R., Zehn, D., Böttcher, J. P., Heikenwälder, M., & Knolle, P. A.
- Affiliations
- Technical University of Munich (DE)
- German Cancer Research Center (DE)
- German Center for Infection Research (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- TUM Klinikum (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Maastricht University (NL)
- Helmholtz Munich (DE)
- University of Freiburg (DE)
- Max Planck Institute of Immunobiology and Epigenetics (DE)
- Innsbruck Medical University (AT)
- Heidelberg University (DE)
- Max Planck Institute of Biochemistry (DE)
- Corresponding author
- Knolle, Percy A.
- ORCID
- Dudek, Michael
- Pfister, Dominik
- Donakonda, Sainitin
- Schneider, Annika
- Hüser, Norbert
- Meiser, Philippa
- Bayerl, Felix
- Inverso, Donato
- Sebode, Marcial
- Öllinger, Rupert
- Rad, Roland
- Anton, Martina
- Guillot, Adrien
- Bowman, Andrew
- Heide, Danijela
- Ramadori, Pierluigi
- Gruber, Tim
- Seifert, Gabriel
- Kabat, Agnieszka M.
- Mallm, Jan-Philipp
- Reider, Simon
- Effenberger, Maria
- Roth, Susanne
- Billeter, Adrian T.
- Müller-Stich, Beat
- Pearce, Edward J.
- Tilg, Herbert
- Thimme, Robert
- Boettler, Tobias
- Tacke, Frank
- Dufour, Jean-Francois
- Haller, Dirk
- Murray, Peter J.
- Heeren, Ron
- Zehn, Dietmar
- Böttcher, Jan P.
- Heikenwälder, Mathias
- Knolle, Percy A.
- Venue
- Nature
- Published
- 2021-03-24
- Volume
- 592
- Issue
- 7854
- Pages
- 444-449
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3139423362
- Semantic Scholar
- d6700d796d9595442696c58e444c2ec3760b0d90
- Cited by
- 518
- References
- 59
- Citations by year
- 2026: 88 · 2025: 101 · 2024: 111 · 2023: 106 · 2022: 70 · 2021: 40
- FWCI
- 38.50
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-05-10)
- Open access
- Licence
- other-oa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Tehran University of Medical Sciences and Health Services
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- nonalcoholic steatohepatitis, T cell exhaustion, FOXO1, IL-15, extracellular ATP, acetate, T cell metabolism, liver inflammation
- MeSH terms
- Receptors, CXCR6, Acetates, Animals, Disease Models, Animal, Humans, Liver, Male, Mice, Inbred C57BL, Cell Death, CD8-Positive T-Lymphocytes, Interleukin-15, Mice, Diet, High-Fat, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. https://app.cochat.ai/papers/10.1038/s41586-021-03233-8
- The paper
- Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., Inverso, D., Wigger, J., Sebode, M., Öllinger, R., Rad, R., Hegenbarth, S., Anton, M., Guillot, A., Bowman, A., . . . Knolle, P. A. (2021). Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. Nature. https://doi.org/10.1038/s41586-021-03233-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.